Table 3. HRs and 95% CIs of the incidence of BTC and IHBDC according to alcohol consumption in men.
Cases | IR per 100,000 | HRa | 95% CI | |||||
Lower | Upper | |||||||
IHBDC | ||||||||
Non drinker | 13 | 7.2 | 1.00 | |||||
Occasional drinker | 7 | 9.1 | 1.57 | 0.62 | 3.98 | |||
Regular drinker (<300 g of ethanol) | 32 | 8.8 | 1.51 | 0.78 | 2.89 | |||
Regular drinker (≥300 g of ethanol) | 26 | 12.5 | 1.96 | 0.99 | 3.91 | |||
P-trend | 0.065 | |||||||
BTC | ||||||||
Non drinker | 61 | 33.7 | 1.00 | |||||
Occasional drinker | 17 | 22.1 | 0.92 | 0.53 | 1.59 | |||
Regular drinker (<300 g of ethanol) | 101 | 27.8 | 1.08 | 0.78 | 1.49 | |||
Regular drinker (≥300 g of ethanol) | 57 | 27.4 | 1.04 | 0.71 | 1.52 | |||
P-trend | 0.702 | |||||||
Subtypes of BTC | ||||||||
GBC | ||||||||
Non drinker | 19 | 10.5 | 1.00 | |||||
Occasional drinker | 6 | 7.8 | 1.01 | 0.40 | 2.57 | |||
Regular drinker (<300 g of ethanol) | 30 | 8.3 | 0.93 | 0.52 | 1.67 | |||
Regular drinker (≥300 g of ethanol) | 12 | 5.8 | 0.71 | 0.34 | 1.51 | |||
P-trend | 0.430 | |||||||
EHBDC | ||||||||
Non drinker | 35 | 19.3 | 1.00 | |||||
Occasional drinker | 7 | 9.1 | 0.72 | 0.32 | 1.63 | |||
Regular drinker (<300 g of ethanol) | 53 | 14.6 | 1.05 | 0.68 | 1.63 | |||
Regular drinker (≥300 g of ethanol) | 38 | 18.3 | 1.23 | 0.76 | 1.99 | |||
P-trend | 0.362 | |||||||
AVC | ||||||||
Non drinker | 7 | 3.9 | ||||||
Occasional drinker | 3 | 3.9 | 1.14 | 0.29 | 4.52 | |||
Regular drinker (<300 g of ethanol) | 12 | 3.3 | 1.01 | 0.39 | 2.58 | |||
Regular drinker (≥300 g of ethanol) | 4 | 1.9 | 0.56 | 0.16 | 1.99 | |||
P-trend | 0.462 |
AVC, ampulla of Vater cancer; CI, confidence interval; BTC, biliary tract cancer; EHBDC, extrahepatic bile duct cancer; GBC, gallbladder cancer; HR, hazard ratio; IHBDC, intrahepatic bile duct cancer; IR, incidence ratio.
aAdjusted for age, study area, body mass index, history of cholelithiasis, history of diabetes mellitus, history of chronic hepatitis or cirrhosis, Japanese tea consumption, and smoking.